Personalis, Inc.PSNL stock score: 45/100

$14.72 · -1.74% · Scored Nov 19, 2026

Technical
51
Fundamental
43
News
—

The reading

Personalis (PSNL) scores 45 out of 100, which reads weak, higher than 34% of Healthcare stocks and 33% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 43, technicals 51.

Among the fundamentals, Revenue Quality (Quarterly) at 100 and Quick Ratio at 99 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 32 and contrarian oscillators 70 — a split worth reading before trusting the technical total.

Since Aug 22, 2026 the composite has ranged from 40 to 50, and it is down 5 points over the period.

About Personalis

Personalis (PSNL) is a U.S. genomics company focused on cancer testing. Its main clinical product is NeXT Personal, a tumor-informed molecular residual disease test that uses whole-genome sequencing of a patient’s tumor to build a personalized blood test, which then tracks tiny amounts of tumor DNA in the bloodstream to detect cancer recurrence or measure response to treatment. The test has Medicare coverage for several clinical uses, including breast cancer and immunotherapy monitoring, and Tempus AI helps sell it to oncologists under a commercial partnership. Personalis also provides genomic sequencing and analysis services to pharmaceutical and biotechnology companies for cancer drug trials and research. Customers include oncologists, cancer centers, drug developers and research institutions. Personalis earns money from clinical test reimbursement, mainly from Medicare and insurers, and from fees for biopharma services. The company has agreed to be acquired by Tempus AI, subject to shareholder and regulatory approvals.

Personalis competes with other molecular residual disease test providers, including Natera, Guardant Health and NeoGenomics. Its edge rests on a whole-genome approach designed for high sensitivity, published clinical data across several cancer types and a commercial channel through Tempus. Investors who follow PSNL stock tend to watch clinical test volumes and growth in Medicare coverage. Reimbursement rates and biopharma service revenue are closely followed. Progress toward completion of the Tempus transaction, operating losses and cash use are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward PSNL’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

43

Pulling it up

  • How the latest quarter's revenue compares with the average of the last four, plus a bonus for steady quarterly revenue.

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

  • Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Absolute profitability: whether the company is profitable, its net margin against the sector range, and how consistently it has been profitable over three years.

  • Operating margins measure profitability after operating expenses.

38 weighted scorers; 1 had no data today and are left out rather than counted as zero.

Technical · daily

39

Pulling it up

  • Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.

  • Simple Moving Average (200-period) is the most widely followed long-term trend indicator.

  • Bollinger Bands (20-period) plot standard deviations above and below a moving average.

Holding it back

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • Stochastic (14) places the close within its 14-day high-low range.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

Technical score by timeframe

ChartScoreWeight
Hourly401
Daily393
Weekly592
Monthly682

Composite score, last 90 days

05010045Aug 22, 2026Nov 19, 2026Aug 22, 2026: 50Aug 23, 2026: 50Aug 24, 2026: 48Aug 25, 2026: 48Aug 26, 2026: 49Aug 27, 2026: 48Aug 28, 2026: 49Aug 29, 2026: 49Aug 30, 2026: 50Aug 31, 2026: 49Sep 1, 2026: 50Sep 2, 2026: 48Sep 3, 2026: 48Sep 4, 2026: 50Sep 5, 2026: 49Sep 6, 2026: 49Sep 7, 2026: 49Sep 8, 2026: 49Sep 9, 2026: 47Sep 10, 2026: 46Sep 11, 2026: 46Sep 12, 2026: 47Sep 13, 2026: 47Sep 14, 2026: 47Sep 15, 2026: 46Sep 16, 2026: 47Sep 17, 2026: 48Sep 18, 2026: 48Sep 19, 2026: 47Sep 20, 2026: 47Sep 21, 2026: 46Sep 22, 2026: 48Sep 23, 2026: 49Sep 24, 2026: 49Sep 25, 2026: 47Sep 26, 2026: 47Sep 27, 2026: 47Sep 28, 2026: 46Sep 29, 2026: 47Sep 30, 2026: 46Oct 1, 2026: 46Oct 2, 2026: 47Oct 3, 2026: 47Oct 4, 2026: 47Oct 5, 2026: 47Oct 6, 2026: 46Oct 7, 2026: 45Oct 8, 2026: 46Oct 9, 2026: 46Oct 10, 2026: 46Oct 11, 2026: 46Oct 12, 2026: 45Oct 13, 2026: 46Oct 14, 2026: 46Oct 15, 2026: 46Oct 16, 2026: 44Oct 17, 2026: 44Oct 18, 2026: 44Oct 19, 2026: 46Oct 20, 2026: 46Oct 21, 2026: 46Oct 22, 2026: 46Oct 23, 2026: 45Oct 24, 2026: 46Oct 25, 2026: 46Oct 26, 2026: 46Oct 27, 2026: 46Oct 28, 2026: 47Oct 29, 2026: 46Oct 30, 2026: 45Oct 31, 2026: 45Nov 1, 2026: 45Nov 2, 2026: 46Nov 3, 2026: 46Nov 4, 2026: 45Nov 5, 2026: 44Nov 6, 2026: 45Nov 7, 2026: 45Nov 8, 2026: 45Nov 10, 2026: 46Nov 11, 2026: 46Nov 12, 2026: 40Nov 13, 2026: 46Nov 14, 2026: 46Nov 15, 2026: 46Nov 16, 2026: 45Nov 17, 2026: 45Nov 18, 2026: 45Nov 19, 2026: 45
Show the daily numbers
DateComposite
Nov 19, 202645
Nov 18, 202645
Nov 17, 202645
Nov 16, 202645
Nov 15, 202646
Nov 14, 202646
Nov 13, 202646
Nov 12, 202640
Nov 11, 202646
Nov 10, 202646
Nov 8, 202645
Nov 7, 202645
Nov 6, 202645
Nov 5, 202644
Nov 4, 202645
Nov 3, 202646
Nov 2, 202646
Nov 1, 202645
Oct 31, 202645
Oct 30, 202645
Oct 29, 202646
Oct 28, 202647
Oct 27, 202646
Oct 26, 202646
Oct 25, 202646
Oct 24, 202646
Oct 23, 202645
Oct 22, 202646
Oct 21, 202646
Oct 20, 202646
Oct 19, 202646
Oct 18, 202644
Oct 17, 202644
Oct 16, 202644
Oct 15, 202646
Oct 14, 202646
Oct 13, 202646
Oct 12, 202645
Oct 11, 202646
Oct 10, 202646
Oct 9, 202646
Oct 8, 202646
Oct 7, 202645
Oct 6, 202646
Oct 5, 202647
Oct 4, 202647
Oct 3, 202647
Oct 2, 202647
Oct 1, 202646
Sep 30, 202646
Sep 29, 202647
Sep 28, 202646
Sep 27, 202647
Sep 26, 202647
Sep 25, 202647
Sep 24, 202649
Sep 23, 202649
Sep 22, 202648
Sep 21, 202646
Sep 20, 202647
Sep 19, 202647
Sep 18, 202648
Sep 17, 202648
Sep 16, 202647
Sep 15, 202646
Sep 14, 202647
Sep 13, 202647
Sep 12, 202647
Sep 11, 202646
Sep 10, 202646
Sep 9, 202647
Sep 8, 202649
Sep 7, 202649
Sep 6, 202649
Sep 5, 202649
Sep 4, 202650
Sep 3, 202648
Sep 2, 202648
Sep 1, 202650
Aug 31, 202649
Aug 30, 202650
Aug 29, 202649
Aug 28, 202649
Aug 27, 202648
Aug 26, 202649
Aug 25, 202648
Aug 24, 202648
Aug 23, 202650
Aug 22, 202650

Key facts

Market cap
$1.6B
Sector
Healthcare
Industry
Diagnostics & Research
Beta
2.36
Risk grade (1–10)
7
Next earnings
Nov 4, 2026

Questions

What is PSNL's stock rating today?

PSNL scores 45/100 (Weak) as of Nov 19, 2026: technical 51, fundamental 43. Scores are recomputed every night.

What does Personalis do?

Personalis (PSNL) is a U.S. genomics company focused on cancer testing.

Is PSNL stock a buy?

The score is not a buy or sell recommendation. A 45 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the PSNL score calculated?

100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

PSNL stock score

HTML

<a href="https://stocksscores.com/stocks/psnl/"><img src="https://stocksscores.com/stocks/psnl/badge.svg" alt="PSNL stock score" height="20"></a>

Markdown

[![PSNL stock score](https://stocksscores.com/stocks/psnl/badge.svg)](https://stocksscores.com/stocks/psnl/)